Neurostimulation for Sleep Disordered Breathing (SDB)

Sponsor
Lunair Medical
Study ID
NCT07243405
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Neuro stimulator implant — DEVICE
    Neuro stimulator for treating sleep disordered breathing

Study Details

This is a study to determine if the Lunair Alpha System is safe and effective for treating moderate to severe sleep disordered breathing.

Key Dates

First listed
Nov 21, 2025
Start date
Jul 30, 2025
Status verified
Apr 2025
Primary completion
Sep 1, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
45 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Alpha Lunair System implanted subjects

Primary Outcome Measure

Safety Endpoint - assessment of procedure or device related adverse events [ Time Frame: enrollment to 12 months post-implant ]

Central Contacts

Related Studies